RFP QuestBeta
Awarded · ResultStage · award

CELL THERAPY CATAPULT LIMITED

Purchase of Alternating Tangential Flow (ATF) Non-GMP Equipment

ValueValue not published
Awarded
Published15 Jul 2026
RegionNationwide
Outcome — awarded
Repligen B.V
Awarded value£288k

This is a contract result notice, not an open opportunity. Details from the official award data.

Who to contact
procurement@ct.catapult.org.uk

The procurement contact named on the official notice.

The brief

CGTC Braintree plan to purchase Non-GMP Alternating Tangible Flow (ATF) equipment in August 2026 to support the development of the process that will be transferred to GMP Manufacturing.

Key requirements

What the supplier must deliver

01

CGTC Braintree plan to purchase Non-GMP Alternating

CGTC Braintree plan to purchase Non-GMP Alternating Tangible Flow (ATF) equipment in August 2026 to support the development of the process that will be transferred to GMP Manufacturing.

Derived from the notice text — always confirm against the original documents.

Buyer intelligence

Make the case to bid

Reveal who to approach at CELL THERAPY CATAPULT LIMITED, and generate a go-to-market strategy from their news, accounts and people.

Source & provenance
OCID
ocds-h6vhtk-06cbf5
Stage
award · Awarded
Source
Find a Tender
Buyer ref
066780-2026
View the original notice on Find a Tender

Contains public sector information licensed under the Open Government Licence v3.0. Source data © Crown copyright.

Market context

Who wins this kind of work

The suppliers and buyers around this opportunity — drawn from official award data. Drag to orbit; click a node to explore.

CELL THERAPY CATAPULT LIMITED’s tender network

Assembling the network…